WO2000073493A3 - A nematode drug screen for modulators of mammalian disorders - Google Patents
A nematode drug screen for modulators of mammalian disorders Download PDFInfo
- Publication number
- WO2000073493A3 WO2000073493A3 PCT/US2000/014678 US0014678W WO0073493A3 WO 2000073493 A3 WO2000073493 A3 WO 2000073493A3 US 0014678 W US0014678 W US 0014678W WO 0073493 A3 WO0073493 A3 WO 0073493A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- modulators
- methods
- disease
- mammalian
- modulate
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5085—Supracellular entities, e.g. tissue, organisms of invertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
- G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
- G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
- G01N2333/43534—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes from Caenorhabditis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
- G01N2400/24—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar beta-D-Glucans, i.e. having beta 1,n (n=3,4,6) linkages between saccharide units, e.g. xanthan
- G01N2400/28—Chitin, chitosan
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU52992/00A AU5299200A (en) | 1999-05-27 | 2000-05-26 | A nematode drug screen for modulators of mammalian disorders |
EP00937874A EP1180165A2 (en) | 1999-05-27 | 2000-05-26 | A nematode drug screen for modulators of mammalian disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13617399P | 1999-05-27 | 1999-05-27 | |
US60/136,173 | 1999-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000073493A2 WO2000073493A2 (en) | 2000-12-07 |
WO2000073493A3 true WO2000073493A3 (en) | 2001-05-31 |
Family
ID=22471665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014678 WO2000073493A2 (en) | 1999-05-27 | 2000-05-26 | A nematode drug screen for modulators of mammalian disorders |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1180165A2 (en) |
AU (1) | AU5299200A (en) |
WO (1) | WO2000073493A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2359627B (en) * | 1999-04-15 | 2002-01-23 | Devgen Nv | Compound screening method |
ATE335002T1 (en) * | 2002-05-15 | 2006-08-15 | Devgen Nv | METHODS FOR THE IDENTIFICATION AND DEVELOPMENT OF COMPONENTS THAT INTERACT WITH POTENTIALLY DEPENDENT POTASSIUM CHANNELS OF THE KV4 FAMILY |
EP1583828A1 (en) * | 2003-01-07 | 2005-10-12 | Genova, Ltd. | Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
JP2008523807A (en) * | 2004-12-15 | 2008-07-10 | シェーリング コーポレイション | Functional assays for cholesterol absorption inhibitors |
CN105738329B (en) * | 2014-12-09 | 2019-05-07 | 费好义 | Screening anti-tumor medicine kit and its application method |
CN105738585A (en) * | 2014-12-09 | 2016-07-06 | 兰州红虫生物工程有限责任公司 | Drug screening kit |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999032619A1 (en) * | 1997-12-23 | 1999-07-01 | The Carnegie Institution Of Washington | Genetic inhibition by double-stranded rna |
WO1999032623A1 (en) * | 1997-12-19 | 1999-07-01 | Pharmacia & Upjohn Company | Human sel-10 polypeptides and polynucleotides that encode them |
WO2000063427A2 (en) * | 1999-04-15 | 2000-10-26 | Devgen Nv | Compound screening method |
-
2000
- 2000-05-26 EP EP00937874A patent/EP1180165A2/en not_active Withdrawn
- 2000-05-26 AU AU52992/00A patent/AU5299200A/en not_active Abandoned
- 2000-05-26 WO PCT/US2000/014678 patent/WO2000073493A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999032623A1 (en) * | 1997-12-19 | 1999-07-01 | Pharmacia & Upjohn Company | Human sel-10 polypeptides and polynucleotides that encode them |
WO1999032619A1 (en) * | 1997-12-23 | 1999-07-01 | The Carnegie Institution Of Washington | Genetic inhibition by double-stranded rna |
WO2000063427A2 (en) * | 1999-04-15 | 2000-10-26 | Devgen Nv | Compound screening method |
Non-Patent Citations (2)
Title |
---|
GEARY T G (REPRINT) ET AL: "Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research", INTERNATIONAL JOURNAL FOR PARASITOLOGY, (JAN 1999) VOL. 29, NO. 1, PP. 105-112. PUBLISHER: PERGAMON-ELSEVIER SCIENCE LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND. ISSN: 0020-7519., PHARMACIA & UPJOHN INC, ANIM HLTH DISCOVERY RES, 301 HENRIETTA ST, KALAMAZOO, MI 49007 (Reprint), XP000972176 * |
GEARY T G (REPRINT): "APPROACHING HELMINTH BIOLOGY FROM THE MOLECULAR DIRECTION", PARASITOLOGY TODAY, (OCT 1996) VOL. 12, NO. 10, PP. 373-375. ISSN: 0169-4758., PHARMACIA & UPJOHN INC, ANIM HLTH DISCOVERY RES, 301 HENRIETTA ST, KALAMAZOO, MI, 49007 (Reprint), XP000972039 * |
Also Published As
Publication number | Publication date |
---|---|
AU5299200A (en) | 2000-12-18 |
EP1180165A2 (en) | 2002-02-20 |
WO2000073493A2 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001071009A3 (en) | Whole-body optical imaging of gene expression and uses thereof | |
PT729468E (en) | NON-PEPTIDIC ANTAGONISTS OF TAQUIKININES RECEPTORS | |
WO2002099051A3 (en) | Nits as modifiers of the p53 pathway and methods of use | |
CA2220461A1 (en) | Therapeutic compounds comprised of anti-fc receptor antibodies | |
DK1054887T3 (en) | Bicyclic pyridine and pyrimidine derivatives as neuropeptide Y receptor antagonists | |
WO2005107491A3 (en) | Multi-lectin affinity chromatography and uses thereof | |
TR200000812T2 (en) | 2-methyl-thieno-benzodiazepine formulation. | |
FI932425A0 (en) | Proteasants and relaters of DNA derivatives | |
IL139163A0 (en) | A method of predicting the ability of compounds to modulate the biological activity of receptors | |
WO2000073493A3 (en) | A nematode drug screen for modulators of mammalian disorders | |
WO2001024781A3 (en) | Gene necessary for striatal function, uses thereof, and compounds for modulating same | |
DE69837267D1 (en) | KCNQ KALIUM CHANNELS AND METHOD FOR MODULATING THEM | |
WO2005000875A3 (en) | Compositions and methods comprising a ligand of chemerin receptor | |
BR9812773A (en) | "polycyclic alpha-amino-epsilon-caprolactams and related compounds" | |
WO2005108599A3 (en) | Compositions and methods for treatment of protein misfolding diseases | |
PT1267915E (en) | METHODS FOR TREATING DISEASES WITH PROTEIN C ACTIVATED | |
ATE420176T1 (en) | THE EAAT2 PROMOTER AND USE THEREOF | |
EP1255110A3 (en) | Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders | |
BR9709245A (en) | Use of a genetic modification in the gene for human protein beta3 subunit for the diagnosis of diseases | |
WO2001066709A3 (en) | Sphingomyelinase enzymes and uses relating thereto | |
WO1999047709A3 (en) | Methods for identifying anti-cancer agents | |
PT1196188E (en) | SELECTIVE MONOCLONAL ANTIBODIES FOR THE FCV AND ITS USE FOR THE TREATMENT OF FCV-RELATED DISEASES | |
WO2002084301A3 (en) | Screening assay for agents modulating activity of the abca1 protein | |
WO2003012103A3 (en) | Nucleic acids coding for novel fbox proteins, their diagnostic and therapeutic uses | |
ITMI951630A0 (en) | MANNEQUIN FOR THE SIMULATION OF HEART DISEASE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000937874 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000937874 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000937874 Country of ref document: EP |